3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Primary Myelofibrosis
12
Polycythemia Vera
11
Myelodysplastic Syndromes
10
Leukemia
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Myeloproliferative Disorders
8
Recurrence
6
Leukemia, Myelomonocytic, Chronic
6
Hematologic Neoplasms
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, T-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Graft vs Host Disease
5
Thrombocythemia, Essential
4
Leukemia, Myeloid, Chronic-Phase
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Interventions
ruxolitinib
1
posaconazole
1
Stem Cell Transplantation
1
Low-Level Light Therapy
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Marrow Neoplasms
×
ruxolitinib
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled